Primary Category:
Treatment Protocols
Disease Category:
Breast, Breast Metastatic
Status:
Closed
A Phase II Trial Assessing the Tolerability of Palbociclib in Combination with Letrozole or Fulvestrant in Patients Aged 70 and Older with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
NCT#03633331
Eligible for screening study DCP 001
Effective Tuesday, March 3rd, 2020, at 4:30 PM ET, study A171601 will be permanently closed to new patient registration.
